THE INTELLIGENCE BRIEFING OF THE INNOVATION ECONOMY
DAILY · SUNDAY · MONTHLY
ISSUE 106 OPENING ESSAY
The Terms Are Part of the Product
A week of financings, credit facilities and acquisitions asks the same question: what can the next person actually count on?
A utility asking a data center developer for a deposit is trying to answer a question the developer's customers may never see. If the project slips, who stands behind the commitment already made to connect it?
Rowan Digital Infrastructure's answer includes $355M in letter-of-credit capacity. That's one piece of the $1.545B in corporate financing it announced this week. A bank can stand behind obligations to a utility or equipment vendor while Rowan keeps cash available for other work. The promise is useful well before a server is plugged in.
The figure I'd underline is the smaller one. The term-loan increase tells you something about how Rowan can finance development. The revolver tells you it can borrow, repay and borrow again. The letter of credit tells you which other people need enough certainty to take a step of their own. Put all three under 'new money' and you lose the reason for having three.
That difference showed up away from the data center, too. At Palomma, the printed round tells you what went into the company. It doesn't tell you why a property manager might introduce it to a tenant or why an owner would trust it with rent. The business gets its first chance because somebody with a relationship already at stake is willing to make the introduction. From there, somebody has to match the rent to the right account and pay the right owner. You don't win that second invitation with a deck.
BlueMatrix has a version of the same problem after completing its Aiera acquisition. It can bring research and new AI tools under one roof. It still has to serve the investment team that expects its feed to work and the research provider that expects a say in how its material is used. The acquisition can change the owner in a day. It cannot ask those customers to relearn what the service promised them by Monday.
The week's Dailies kept finding people in that position. In Issue 103, a tax professional still had to make a judgment the next version of Blue J is being designed to support. In Issue 104, Roku's partners had a reason to care how the platform worked after FOX took ownership. On Saturday, Tristar's night-shift example asked whether the person who found a problem could still do something about it before the next sheet ran. Each had something to lose if a better capability came with an unclear handoff.
There's a way to read the capital ledger that makes these decisions easier to see. Before asking whether the number is large, ask who can do something on the strength of the agreement. The developer can proceed with an obligation that a bank will back. The buyer may have to wait for approvals before it can change a thing. The fund manager has commitments to invest, not a tally of work already done. The answers are different, and that is precisely why those numbers earn separate lines.
The most useful part of an announcement can be the sentence that tells you what happens if the plan is late. That's where you find out who is expected to wait, who can ask for proof and who signed up to go first.
A promise matters when somebody else can make a plan around it.
Opening sources: Rowan Digital Infrastructure | Palomma | BlueMatrix / Aiera
Here's to Cipriano Echavarría, Anubhav Sharma, Shlomi Yanai, Harrison Chase, Ken Sena, Juhana Kallio, Feng Yu, Pavel Digaňa, Stephan Kuehr, Braham Mehta, Ashraf Nehru, and Charley Daitch. Keep pushing forward!
What the Capital Committed To
The weekly record covers 176 moves published by DevCuration after 3 a.m. Eastern on November 8 and through 3 a.m. Eastern on November 15. The ledger includes several earlier announcements that DevCuration published during this window. The six published Dailies account for 117 records. The remaining 59 first appear in this Sunday record, including the twelve full memos below.
Across the Dailies and Sunday-only records, the 59 counted company financings add to about $5.0B using dollar figures as stated. About $4.7B came from records the Dailies carried and $0.3B from Sunday-only records. Mirendil, UFORCE and Agile Robots account for $2.2B, or 43.6%. This is not a U.S.-dollar conversion or a measure of cash received.
The Sunday subtotal uses a narrower rule than some individual Dailies. Packages such as Mercor's employee tender, Blue J's financing with secondaries and Nanopath's financing with grants stay in the ledger but outside the subtotal. Earlier disclosures, qualified amounts, rounds with unclear instruments and non-dollar amounts also stay outside it.
Read the commitment before treating the number as money in the bank.
The Week's Dailies
Issue 100: The Record Is Large Enough to Disagree
The milestone issue drew a line between company financing and other capital structures. 12 records in this ledger. Largest counted financing: Alethio Therapeutics ($90M).
Issue 101: The Question the Product Cannot Answer Alone
A sale is also an agreement about what work the customer hands over. 12 records in this ledger. Largest counted financing: Onodrim ($300M).
Issue 102: The Work That Earns the Next Yes
A first transaction opens the relationship; the next one tests it. 12 records in this ledger. Largest counted financing: Nominal ($240M).
Issue 103: Somebody Still Has to Grade the Answer
Applying AI to a decision still leaves someone responsible for judging the answer. 12 records in this ledger. Largest counted financing: Path Robotics ($300M).
Issue 104: The Customer Still Has a Say
A change in ownership does not erase the obligations to customers and partners. 36 records in this ledger. Largest counted financing: Rox ($100M).
Issue 105: When the Answer Reaches the Line
An alert matters when the person on the line can act before the next mistake. 33 records in this ledger. Largest counted financing: Mirendil ($1B).
Reach the founders, investors and operators following the work after the announcement.
Partner with WTMMCapital by Type
Disclosed company financing (59) $5.048B as stated, including $4.7237B from Dailies and $324.3M Sunday-only.
Debt and credit (4) $1.725B across three quantified standalone credit records: Rowan, Calibrant and Connie Health. PortX was undisclosed. Figures are capacity, not draw balances.
Funds and commitments (25) $5.9795B across nine specified dollar closes, excluding targets, earlier/cumulative sizes and debt sidecars. Separately: €465M across Intera and Robin; S$70M at NeoSci’s first close.
Acquisitions and ownership (34) FOX/Roku closed at about $22B in announced enterprise value. Pending transactions include the $15.3B enterprise value for Thrive/ADT and £215M in stated Yamaha/Disguise consideration. These are not added together.
Other financing structures (54) Original-currency, historically disclosed, mixed, cumulative, conditional and undisclosed amounts. Nanopath’s $2M of grants is identified within its package, not added as a second record.
Top 10 Disclosed Financings
Equal amounts share a rank. Dollar figures are as stated.
1. Mirendil $1B · Series A
2. UFORCE $700M · Series A
3. Agile Robots $500M · Series C and later
4. Onodrim $300M · Series A
4. Path Robotics $300M · Series C and later
4. LangChain $300M · Series C and later
7. Q-CTRL $290M · Series C and later
8. Nominal $240M · Series C and later
9. Neurosterix $105M · Series B
10. Delix Therapeutics $100M · Series C and later
10. Rox $100M · Series B
10. Databento $100M · Series C and later
Disclosed financing by stage
Bar length represents stated dollars; labels show amount and record count.
What the Agreements Make Possible
Disclosed financing by sector
Same $5.048B and 59 financings as the stage view. Each company is counted in one sector.
Investor leaderboard
Counted financings with named investor credits in full Daily memos only. These are repeated appearances in that subset, not a rank across all 176 moves.
T-1. Salesforce Ventures 2 rounds: Reflect Orbital | Q-CTRL
T-1. Sequoia Capital 2 rounds: Reflect Orbital | Rox
Put judgment where it can change the result
Blue J’s proposed Workflows, Tristar’s factory inspections and Kardi Ai’s shareable ECG recordings all move evidence closer to a decision. That helps only if the recipient gets the context and time to act.
Blue J Raises $176M Series E for Agentic Tax Workflows | Tristar AI Raises $12.4M for Factory Quality Inspection | Kardi Ai
Buy access without losing the people who granted it
FOX/Roku, IBM/AuthMind and BlueMatrix/Aiera transfer ownership of different kinds of access. The work after closing is keeping publishers, teams and users confident enough to rely on the service.
FOX Completes Roku Acquisition as Open-Platform Owner | IBM / AuthMind | BlueMatrix / Aiera
Use different instruments for different obligations
Rowan’s term-loan increase, revolver and letters of credit belong in a different comparison from LangChain’s priced Series C or Intera’s fund close. All three are useful, but to different people and on different terms.
All 176 Moves
Each record appears once and links to its DevCuration record. F: counted financing. C: credit. V: fund or commitment. M: acquisition or ownership. O: other financing. A number after # points to a Daily issue; S means Sunday-only.
- 001 · Mindmax
F · $3.3M FINANCING | ROUND STAGE UNDISCLOSED · #100 - 002 · Fact Base
O · ¥4.5B SERIES D PACKAGE | NEW AND SECONDARY SHARES, SPLIT UNDISCLOSED · #100 - 003 · Dronamics / GP-Act III
M · Proposed combination; $400M pre-money equity value, not proceeds · #100 - 004 · Supa
O · £21M | Seed · S - 005 · Oakley Capital
M · Acquisition · S - 006 · NoBlue2 / PeopleWalking
M · M&A · S - 007 · Ottonomy
O · PRE-SERIES A INVESTMENT | AMOUNT UNDISCLOSED · #100 - 008 · Sapphiros / binx health
M · COMPLETED SAPPHIROS / BINX HEALTH COMBINATION | NEW CAPITAL UNDISCLOSED · #100 - 009 · Copilot Capital
M · M&A · S - 010 · Whisper Aero
O · $46.3M | Equity Financing · S - 011 · Macquarie Consortium
M · M&A · S - 012 · Gravis Robotics
O · August announcement; earlier $200M Series A · S - 013 · Andavi
M · Acquisition · S - 014 · Soter Insure
O · SERIES B SECOND CLOSE | AMOUNT UNDISCLOSED · #100 - 015 · Monumental
O · Earlier $32M Series B, announced in July · S - 016 · August Robotics
O · May announcement; earlier $30M Series B · S - 017 · Axiom
O · Agreed $2B preferred investment; October announcement; pending at the time of the record · S - 018 · All3
O · April announcement; earlier $25M Seed · S - 019 · Alethio Therapeutics
F · $90M SERIES A · #100 - 020 · bit.bio
F · $25M SERIES D · #100 - 021 · Siggy
F · $6M PRE-SEED · #100 - 022 · Cephable
O · $7M | Seed · S - 023 · SoftBank / ABB Robotics
M · $5.375B PROPOSED ACQUISITION | CHINA PORTION PROHIBITED | TALKS CONTINUE · #100 - 024 · Nums AI
O · KRW 2B | Pre-Seed · S - 025 · Atmospheric AI
F · $10.1M SEED · #100 - 026 · Houmo.AI
O · Several billion yuan | Series B · S - 027 · Aulis Capital
V · $200M FUND I FINAL CLOSE | REPORTED NOVEMBER 5 · #100 - 028 · Bpifrance
V · €75M fund launch; not a disclosed close · S - 029 · Valor Equity Partners
V · $3.29B cumulative sales across filings; no final close established · S - 030 · Yosemite
V · $350M | Fund Close · S - 031 · Ballistic Ventures
V · $490M combined targets; no reported sales at filing · S - 032 · Flashpoint Capital
V · $116M fund final close + $25.5M separate debt sidecar · S - 033 · NeoSci Ventures
V · S$70M first close · S - 034 · DENMU Fund I
V · Final close above $50M target; actual size undisclosed · S - 035 · SCVC
V · About $20M initial close, reported · S - 036 · Evertrue Capital
V · $17M | Fund I Final Close · S - 037 · Robin Capital
V · €15M | Fund II Final Close · S - 038 · Daksham Growth Ventures
V · About $13.3M at first close, reported using conversion · S - 039 · Octopus Ventures
V · Fund First Close · S - 040 · Ondine Capital Fund III
V · First Close · S - 041 · Talde
V · €100M target; no first close confirmed · S - 042 · Uranium Digital
F · $16.5M SERIES A · #101 - 043 · Volition Capital
V · $950M final close announced in September · S - 044 · Rivio
O · R$80M SERIES A EXTENSION | R$180M ROUND TOTAL (original currency) · #101 - 045 · Thrive / ADT
M · PENDING ACQUISITION | $15.3B ENTERPRISE VALUE | ABOUT $7.6B EQUITY VALUE · #102 - 046 · Marble Imaging
O · €6M SEED EXTENSION | €11.3M COMBINED SEED FUNDING (original currency) · #101 - 047 · Synctera
O · $24.5M mixed financing; about $9.5M equity, remainder venture debt · #101 - 048 · Onodrim
F · $300M SERIES A | $1.3B VALUATION · #101 - 049 · Physicl
F · $10M SEED · #101 - 050 · Spines
O · $29M equity plus $35M growth facility; not counted as one equity raise · #101 - 051 · Delix Therapeutics
F · $100M SERIES C · #101 - 052 · Phaze Ventures
V · MORE THAN $40M COMMITMENTS | TWO FUNDS | MORE THAN $75M TARGET · #102 - 053 · Mavria
O · $130M CUMULATIVE PRE-SEED AND SEED | LATEST AMOUNT UNDISCLOSED · #101 - 054 · Vessel
F · $5M SEED · #101 - 055 · Project Omega
F · $80M SERIES A · #101 - 056 · geniosAI
O · $19.1M COMBINED SEED AND SERIES A | COMPONENTS UNDISCLOSED · #102 - 057 · Coframe
F · $25M SERIES A | $35M TOTAL FUNDING · #101 - 058 · Astral
O · $5.5M TOTAL FUNDING | LATEST COMPONENT UNDISCLOSED · #102 - 059 · Snapp
O · $4.6M FUNDING DISCLOSURE | INCREMENTAL RELATIONSHIP UNRESOLVED · #102 - 060 · IINO Lines
V · LP commitment; amount undisclosed · #102 - 061 · Vanta / Pillar Security
M · PENDING ACQUISITION | ABOUT $150M REPORTED | OFFICIAL PRICE UNDISCLOSED · #102 - 062 · Aldaron
V · $884M final close; $67M of co-investments is separate · #102 - 063 · Dechra / Gallant
M · PENDING ACQUISITION | TERMS CONFIDENTIAL · #102 - 064 · Ridero
O · $2.7M CUMULATIVE PRE-SEED | LATEST COMPONENT UNDISCLOSED · #102 - 065 · Blackletter
F · $6M SEED · #102 - 066 · Nominal
F · $240M SERIES C | $3B VALUATION · #102 - 067 · Lombard Systems
O · $4M across two rounds; split undisclosed · S - 068 · Sparxity
O · Series A amount undisclosed; $90M cumulative · S - 069 · Ancep
O · $8.5M new funding; instrument not established in the record · S - 070 · Kinneberg Management Group
O · Growth · S - 071 · Blue J
O · $176M announced; includes secondary purchases; primary split undisclosed · #103 - 072 · Alterra Labs
F · $12.5M SEED · #103 - 073 · Bay
F · $37M SERIES A | PLUS PREVIOUSLY UNDISCLOSED $13M SEED · #103 - 074 · Mercor
O · $750M announced; includes an employee tender; primary split undisclosed · #103 - 075 · PromptPath
F · $12M | Series A · S - 076 · Nanopath
O · $25M announced; includes $2M non-dilutive grants · #103 - 077 · Charta Health
F · $55M SERIES B | $85M TOTAL FUNDING REPORTED · #103 - 078 · American AI Logistics
O · Series B · S - 079 · Nidus
O · $30M COMBINED PRE-SEED AND SEED | COMPONENTS UNDISCLOSED · #103 - 080 · Path Robotics
F · $300M SERIES E | $2.45B POST-MONEY VALUATION · #103 - 081 · Cribl / Tero
M · Acquisition · S - 082 · Clara
O · $65M equity and a $40M renewed growth facility · #103 - 083 · Zus Health
F · $33M SERIES B | MORE THAN $100M TOTAL FUNDING REPORTED · #103 - 084 · Zacua Ventures
V · $135M | Fund Close · S - 085 · OpenAI / Odessia
M · COMPLETED ACQUISITION | PRICE UNDISCLOSED · #103 - 086 · Lumbra
F · $25M SERIES A · #103 - 087 · Oura / Counsel Health
M · $625M cash acquisition agreement | Pending · #104 - 088 · SPARETECH
F · $20M Series B · #104 - 089 · EnVision Endoscopy
F · $11.5M Series A · #104 - 090 · Calibrant Energy
C · US$145M project debt facility · #104 - 091 · WhiteMatter
F · $20M Series A · #104 - 092 · Triplemoon
F · $4M seed extension · #104 - 093 · Mosaic Intelligence Labs
O · $47M disclosed across seed rounds · #104 - 094 · Index Industries
F · $50M seed · #104 - 095 · iCareManager
O · Growth investment | Terms undisclosed · #104 - 096 · PuppyGraph
F · $10M Series A · #104 - 097 · Garage
F · $41M Series B · #104 - 098 · Graphon Labs
F · $35M Series A · #104 - 099 · Tendrils Compute
F · $30M financing | Seed per Visionaries Club · #104 - 100 · Finite State
F · $27M Series C · #104 - 101 · Sumary
F · US$25M seed · #104 - 102 · Marble
F · $11M seed · #104 - 103 · Siemens / Lauterbach
M · Acquisition agreement | Terms undisclosed | Pending · #104 - 104 · MaxCyte / Akron Bio
M · US$151.8M acquisition agreement | Cash, stock and deferred payments | Pending · #104 - 105 · FOX / Roku
M · Completed; approximately $22B announced enterprise value · #104 - 106 · AstraZeneca / Omniose
M · Completed acquisition | Terms undisclosed · #104 - 107 · Diamondback / KKR / Deep Blue
M · 70% stake purchase agreement | Price undisclosed | Pending · #104 - 108 · redalpine
V · $250M final close · #104 - 109 · Mubadala Capital / LSV Advisors
M · Minority stake agreement | Terms undisclosed | Pending · #104 - 110 · Lawfty
O · Strategic investment | Terms undisclosed · #104 - 111 · Torus
O · $500M growth capital; instrument mix undisclosed · #104 - 112 · Operand
O · $31M reported across seed and Series A | $30M separately described by founder · #104 - 113 · Reflect Orbital
F · $73.5M new financing | Round series not disclosed · #104 - 114 · Connie Health
C · $35M asset-backed revolver | Expandable to $100M · #104 - 115 · PortX
C · Non-dilutive growth financing | Amount undisclosed · #104 - 116 · Plurai
F · $13M seed · #104 - 117 · Marsh / Wilshire
M · Acquisition agreement | Terms undisclosed | Pending · #104 - 118 · Rox
F · $100M Series B | $1.3B valuation · #104 - 119 · Coreshell
F · $30M Series B · #104 - 120 · Nebuly
F · $21M Series A · #104 - 121 · Axle
F · $9M financing | Seed per Axios · #104 - 122 · Kindo
O · $30M expansion financing | Instrument undisclosed · #104 - 123 · Francis Medical
O · Undisclosed financing · #105 - 124 · MyoWorks
O · Undisclosed Pre-Seed investment · #105 - 125 · Skribe Medical
O · Previously disclosed Pre-Seed backing · #105 - 126 · Araceli Biosciences
O · Previously closed; new investor amount undisclosed · #105 - 127 · Hatz AI
F · $24M Series A · #105 - 128 · XpertDox
F · $20M Series A · #105 - 129 · Imprint
O · $130M financing at about $1.9B valuation; instrument undisclosed · #105 - 130 · Helix
F · $6.2M Pre-Seed · #105 - 131 · Akara
F · $5.5M · #105 - 132 · Qvyon
O · Earlier mixed Seed equity and venture debt · #105 - 133 · Alma Mater Footwear
O · Undisclosed strategic investment · #105 - 134 · Duet
F · $15M Series A · #105 - 135 · Tristar AI
F · $12.4M Series A · #105 - 136 · Databento
F · $100M Series C · #105 - 137 · Delphina
O · $7.5M in new funding; instrument undisclosed · #105 - 138 · Athlete To Athlete
F · $8M Series A · #105 - 139 · Mount Thor
O · $45M Seed and Series A · #105 - 140 · VulcanForms
O · $500M financing agreement; instrument not disclosed · #105 - 141 · Light Frame
F · $5.1M Seed · #105 - 142 · Proximal Ventures
V · $27.5M Fund I · #105 - 143 · Mirendil
F · $1B Series A · #105 - 144 · 4Minds
F · $15M Series A · #105 - 145 · Norwest
V · $4B Fund Close · #105 - 146 · Q-CTRL
F · US$290M Series C · #105 - 147 · UFORCE
F · $700M Series A · #105 - 148 · Agile Robots
F · $500M Series F · #105 - 149 · Mondrio
O · $3.75M Funding Round · #105 - 150 · Neurosterix
F · $105M Series B · #105 - 151 · The 81 Collection
V · Additional close; $82M total fund size, not increment · #105 - 152 · Twin1 AI
F · $5M Seed Extension · #105 - 153 · vinny
F · $2.1M Seed · #105 - 154 · Clawlab
O · >$15M Pre-A3 · #105 - 155 · Lumepay
O · $6M Pre-Seed closed earlier in 2026; float separate · #105 - 156 · Bluestone / 11th St. Workshop
M · M&A · S - 157 · Palomma
F · $10M Series A; excludes $4M previously raised · S - 158 · Baaz Bikes
O · ₹46.22 crore board-approved according to filing-based reporting; about $4.91M converted; not confirmed closed · S - 159 · IBM / AuthMind
M · Acquired; terms undisclosed · S - 160 · LangChain
F · $300M Series C at $3B valuation; November 13 announcement · S - 161 · BlueMatrix / Aiera
M · Acquisition completed; terms undisclosed · S - 162 · smartTrade / Celoxica
M · M&A · S - 163 · Intera Partners
V · €450M final close; original currency · S - 164 · Eli Radiopharma
O · Nearly RMB400M Series A; original currency, qualified · S - 165 · Kardi Ai
O · More than €5.3M Series A; original currency, qualified · S - 166 · Opdo
F · $2.3M Pre-Seed · S - 167 · York Space / Outlook Industries
M · M&A · S - 168 · Avanade / Robiquity
M · M&A · S - 169 · Securitize / River One
M · Signed agreement; price undisclosed; closing pending · S - 170 · XRHealth / PursueCare
M · M&A · S - 171 · Ellipsis Health / Kouper
M · Acquisition · S - 172 · eToro / LB Finanzas
M · M&A · S - 173 · Inovalon / DrFirst
M · Acquisition · S - 174 · Yamaha / Disguise
M · £215M consideration for shares and shareholder loan notes; completion pending approvals · S - 175 · Trusted Space / Falcon ExoDynamics
M · M&A · S - 176 · Rowan Digital Infrastructure
C · $600M term-loan increase + $590M revolver + $355M letters of credit · S
Twelve records that did not appear in this week's Dailies.
Palomma
Palomma's first customer can introduce it to both sides of the rent payment. A property manager already works with the tenant sending the money and the owner waiting for it, giving the Medellín company a route into financial services through a relationship somebody else has spent years building. The commercial advantage begins with that introduction.
Co-founder and CEO Cipriano Echavarría, CTO Felipe Monsalve and co-founder Nicolás Gómez del Campo have raised a $10M Series A led by COMETA. Disclosed on November 11, the round brings total funding to $14M, including $4M in earlier, previously undisclosed capital.
Volpe Capital, Clocktower Technology Ventures, Tekton Ventures, Simma Capital and Yango Ventures participated, alongside returning investors Y Combinator, 17Sigma, Nido Ventures and Norte Ventures. The capital will deepen Palomma's Colombia business and support more AI and financial products, with international expansion still being evaluated.
The founders entered Y Combinator's Winter 2023 batch building account-to-account payments. Property managers then asked for help collecting rent. That request gave the payments business a customer with recurring work, a network of owners and tenants, and good reasons to keep coming back every month.
Palomma now combines AI agents for leasing and service with rent collection, reconciliation and payouts. The company says it serves over 500 property managers and more than 200,000 tenants. COMETA's investment statement puts annualized rent volume above $1.5B, money passing through the platform rather than revenue belonging to it.
The same relationship opens other conversations. An owner may want access to future rental income. A manager may want protection when a tenant misses payment. Palomma Advance and Palomma Protect put financing and rental guarantees beside the payment workflow, with eligibility and contract terms still doing consequential work.
That is a demanding customer relationship to expand. The agency choosing collection software is also introducing financial products to people whose homes and income are involved. A useful payment record can inform a lending decision; taking responsibility for that decision brings its own obligation.
Palomma's Colombia-first plan gives those agency relationships more work to carry. As the product range grows, the manager who first asked for help collecting rent becomes part of how the next owner encounters financing and the next tenant encounters a guarantee.
Deeper Analysis 👇 https://devcuration.com/articles/palomma-10m-series-a-cometa-rent-finance
Baaz Bikes
Getting a delivery rider onto a scooter creates another customer for the battery network, the repair team and the software keeping the shift moving. Baaz Bikes has built its business around taking those responsibilities together.
For the rider, a subscription can remove the upfront vehicle purchase. For Baaz, that same arrangement puts equipment and service behind a recurring payment. A scooter sitting idle still needs someone to pay attention to it.
Entrackr reports that Baaz's board has approved about $4.91M in Series B financing, led by BIG Capital, with Kalaari Capital and Aravind Sanka participating. The reported amount is ₹46.22 crore, converted approximately using November 13's RBI/FBIL reference rate. This is an ongoing round at the board-approval stage.
CEO Anubhav Sharma and CTO Shubham Srivastava are co-founders alongside Abhijeet Saxena and Karan Singla. The IIT Delhi team's assignment reaches from the scooter to the swap station, with software and service holding the relationship together after a rider signs up.
The company describes automated battery swaps, weekly subscriptions and on-road and hub servicing. Its live website lists Delhi NCR as operating, with Bengaluru and Mumbai marked coming soon. Geography matters when the product depends on equipment a rider has to reach during a working day.
Station coverage also belongs in the customer decision. For a rider comparing weekly costs, the distance to a charged battery can matter alongside the subscription price and the scooter itself.
The reported proceeds are intended for capital expenditure, product development and working capital. Those are closely connected uses for this model: put equipment into service, improve how it works, and keep the operation supplied while subscription payments come in.
BIG Capital led Baaz's $8M Series A in 2023. Kalaari's portfolio records its initial investment in 2022. Their return brings an existing relationship into the next financing decision, with the practical work of running a delivery network still attached.
There is a commercial choice here for anyone building around access rather than ownership. Making it easier for a customer to start means accepting more responsibility for what happens after the start. Baaz carries that choice into batteries, spare parts and the next service call.
A new delivery app can send another order to a phone. Somewhere nearby, a charged battery and a working scooter have to be ready for the person who accepts it.
Deeper Analysis 👇 https://devcuration.com/articles/baaz-bikes-board-approves-series-b-big-capital
IBM / AuthMind
IBM invested in AuthMind in 2023, signed an OEM agreement in 2024, and is now bringing the company inside IBM. Along the way, the work moved closer to a difficult security decision: when should an agent that was allowed into the system lose its access?
IBM disclosed the acquisition on November 12. AuthMind joins a HashiCorp Vault strategy that connects an agent's identity and delegated authority with the actions it takes. Financial terms were not disclosed.
Shlomi Yanai, co-founder and CEO, and Ankur Panchbudhe, co-founder and CTO, built AuthMind around observing identity activity. Founded in 2020, the Bethesda company also has R&D operations in Pune. Its subject includes human users, machine identities and AI agents, all moving through environments where a valid credential can accompany an unexpected action.
For a security team, that creates an awkward assignment. The system approved the access. The software is doing work. Somebody now has to establish whether the activity still belongs inside the authority that was granted, and whether stopping it will interrupt something the business needs. The decision has to stay understandable to the team carrying the incident.
Vault manages secrets and short-lived credentials. AuthMind adds visibility into how identities retrieve and use them across applications and systems. IBM describes an identity activity graph that connects identities, resources and access paths, giving an analyst context for unusual behavior.
There is commercial history behind that fit. Ballistic Ventures led AuthMind's 2023 seed investment, with IBM Ventures participating. Cheyenne Ventures led a $19.3M seed round announced in April 2025. The 2024 OEM agreement brought AuthMind's technology into the IBM Verify relationship; a September 2026 announcement extended the collaboration around Vault.
Acquiring a supplier you already work with changes who can coordinate the roadmap. IBM can pursue deeper integration between the system issuing a credential and the technology observing its use. Customers will need to see how that connection reaches the person responsible for an intervention, especially when an agent hands work to another agent.
The useful product conversation now runs through the analyst's desk: which identity took the action, whose authority traveled with it, and what can be restricted while the rest of the workflow keeps running. AuthMind's place inside IBM brings those questions closer to the Vault team building the controls.
Deeper Analysis 👇 https://devcuration.com/articles/ibm-acquires-authmind-ai-agent-identity-security
LangChain
A developer can skip LangChain's frameworks and still become a LangSmith customer. Harrison Chase and Ankush Gola have given the business a way to earn money beyond the code that made it famous.
The co-founders, CEO and CTO respectively, now have a $300M Series C at a $3B valuation behind that choice. CapitalG led the round, with GIC and DFJ Growth joining IVP and Sapphire Ventures. Salesforce Ventures also joined the financing, bringing another enterprise software investor into a company selling the infrastructure around agents.
LangChain began as Harrison Chase's open-source project in 2022 and became a company in early 2023. LangChain and LangGraph helped developers build agents; LangSmith gives teams a commercial place to run them, inspect their behavior, evaluate changes and govern access. Customers can bring a different framework. That invitation makes the addressable relationship larger than the framework community.
An enterprise can buy access to a capable model from the same supplier as its competitor. Its own advantage has to develop somewhere: in the context an agent receives, the tools it can use and the accumulated evidence about which decisions worked. Somebody inside the company still has to define a good result.
LangSmith sits close to that evidence. A production trace can become an evaluation case; an evaluation can help a team decide whether changing a model or prompt has improved the agent. The customer is building a record of its own operating judgment while the underlying models keep moving.
LangChain says more than 7,000 organizations rely on LangSmith. A November 10 case study puts a useful boundary around the speed claim: Workday teams could get an agent prototype into staging in under a day, compared with 4-5 months previously. That leaves production approval with the people responsible for it.
CapitalG first invested in the $125M Series B announced in October 2025, at a $1.25B valuation. Returning as the Series C lead gives its belief in neutral agent infrastructure a much larger commitment. The company has also extended LangSmith into runtime, improvement and governance, widening the work it can take on for that customer.
For Harrison Chase and Ankush Gola, the commercial opportunity keeps expanding with the customer's agent estate. Each new workflow brings another set of failures to understand, permissions to manage and evaluations somebody has to trust before replacing the model underneath it.
Deeper Analysis 👇 https://devcuration.com/articles/langchain-raises-300m-series-c-at-3b-valuation
BlueMatrix / Aiera
David Nable has made Aiera's existing service expectations part of BlueMatrix's acquisition story. An investment team already depending on its research feed still needs that feed when the ownership changes.
On November 12, BlueMatrix completed its acquisition of Aiera, backed by majority shareholder Thoma Bravo. Financial terms remain undisclosed. The October agreement has become a combined business with customers to serve on both sides of the research trade.
Nable, BlueMatrix's CEO, is bringing together infrastructure that helps institutions write and govern research with technology that carries proprietary financial content into AI workflows. Aiera co-founders Ken Sena, CEO, and Bryan Healey, CTO, built the access business around research providers retaining a say in how their material gets used.
That constituency matters. Aiera announced a $25M Series B in June 2025 with a consortium of major research institutions. Fin Capital and Flybridge Capital Partners are among its historical backers. Those relationships come with the product, alongside the expectations of the investment professionals consuming the content.
BlueMatrix has its own history to carry forward. Patricia Horotan and Skye Hauptman founded the company in 1999; Horotan now serves as founder and CSO. With CTO Donald Prodehl, the business has been extending the publishing workflow toward AI consumption. BlueMatrix says its network serves more than 1,000 financial institutions.
The software was moving before the deal closed. On October 27, BlueMatrix made Portal AI Search & Chat and Portal Connect MCP generally available. Aiera already offers APIs and Model Context Protocol connections for delivering financial content inside clients' existing tools. Combining them means joining working products and established customer habits.
For a research provider, permission is a commercial decision. An institution can want its analysis inside a client's AI workflow while setting conditions on access, attribution and reuse. BlueMatrix's Research Provenance Standard encodes declared rights and source attribution into structured research; Aiera supplies another route into the environment where questions get asked.
The acquisition concentrates more of that coordination inside one vendor. Nable's service commitment now travels with Sena's provider relationships, through the investment team's next earnings call, next filing and next question to its research assistant.
Intera Partners
Intera Partners wants the people running a business to keep owning a meaningful part of it after the buyout. That choice gives the entrepreneur a continuing stake in the expansion their new investor came to finance.
Managing Partner Juhana Kallio now has a larger fund behind that arrangement. Intera Fund V reached its €450M hard cap, above a €375M target, at an oversubscribed final close announced November 3. The Finnish firm will keep backing entrepreneur-led service and technology companies in Finland and Sweden. The mandate stays familiar as the capital gets bigger.
A majority of commitments came from existing investors. New institutional partners joined, and Finnish investors increased their commitments from Fund IV. Pension funds, foundations, insurers and institutional funds of funds are represented; individual LP names remain undisclosed. People who already knew the manager supplied most of the new vehicle's backing.
Intera's ownership model puts that continuity to work inside the companies. Its published criteria include €10M–€200M in revenue, predictable positive cash flow and the possibility of majority ownership. Management remains a significant co-owner. Acquisitions, board work and international expansion sit alongside organic growth, giving the operating team several assignments to carry together.
The Suvia example makes those assignments tangible. Intera's vehicle-damage services company expanded into Belgium through AutoRepairGroup in August. The Belgian name, management and customer arrangements stayed in place while the businesses gained access to each other's specialist experience. A larger repair group still needs the people who understand the local workshop, insurer and customer.
That transaction illustrates Intera's approach; the firm has not identified it as a Fund V investment. Nor should a larger fund be confused with money already deployed. Fund IV closed at €335M in 2021. Fund V adds about 34% to that vehicle's size, with the same regional emphasis and a bigger ambition for the businesses it backs.
Tuomas Lang, Jokke Paananen and Harri Hollmén founded Intera in 2007. The ownership idea running through its current approach keeps the entrepreneur inside the story long after signing. As Kallio's team brings more capital into Finnish and Swedish companies, those management co-owners will still be making the decisions in board meetings and on the ground that have to travel well beyond home.
Eli Radiopharma
A molecular-imaging researcher joining Eli Radiopharma is expected to design experiments, label isotopes, optimize quality control and help other scientists interpret the results. That job description puts a useful human scale on a nearly RMB400M financing.
Feng Yu, founder, CEO and board chairman, is building a company whose next stage asks more of each promising molecule. Eli Radiopharma's Series A, announced November 12, was led by Huagai Capital, with Bayland Capital as co-lead. Boyu Ventures and Delian Capital joined new and returning backers.
The Hangzhou company develops diagnostic and therapeutic radiopharmaceuticals for oncology and neurological diseases. It combines molecular targeting with radionuclide technology, with a pipeline spanning diagnostic imaging and therapeutic programs. The work travels through experiments, regulatory applications and clinical evaluation before patients can benefit.
Feng Yu has worked across those handoffs. Eli Radiopharma's biography describes earlier leadership at Suzhou BoomRay and APRINOIA Therapeutics, including responsibility for translational research and registration. He founded Eli Radiopharma in 2024; the company reported RMB300M in financing by March 2026, before this Series A.
The new proceeds are intended for preclinical studies, clinical applications, early clinical development, R&D platforms and talent. Several candidates are approaching IND submissions, according to the announcement. Separately, the company reported Chinese trial authorization for its ELI-101 tau PET tracer in March. That permission starts a research assignment; patient outcomes still require clinical evidence.
There is a commercial relationship developing alongside the science. Eli Radiopharma's collaboration with HTA combines early R&D with supply-chain capabilities under a joint-development arrangement. The disclosed economics include payments tied to clinical achievements and future net sales, linking clinical progress to partnership economics.
For the scientific team, another round expands the work that can run together: discovering candidates, preparing evidence and coordinating with partners. The molecular-imaging vacancy reaches into labeling, purification and quality-control procedures. Scientists must turn a molecule into material another team can study.
Eli Radiopharma is now funding more of that passage from a research result to a clinical question, with researchers and development partners carrying the next handoff.
Deeper Analysis 👇 https://devcuration.com/articles/eli-radiopharma-nearly-rmb-400m-series-a
Kardi Ai
The recording ends. The cardiologist still needs a record of what happened while the patient was getting on with life. Kardi Ai has built a business around keeping that information within reach.
The Olomouc, Czech Republic company combines an ECG chest strap, a mobile app and AI analysis. Users can take repeated measurements at home, keep a history and share the results with their doctor. That gives an intermittent rhythm problem more opportunities to appear in a record a clinician can actually use.
Now the company has raised over €5.3M in Series A financing led by Callisto Health. The Seed Starter programmes of Česká spořitelna and Slovenská sporiteľňa joined BrightCap Ventures, Purple Ventures, DEPO Ventures and Garage Angels in the round, announced November 11.
CEO Vlastimil Hrabal and CTO Pavel Digaňa have an expansion assignment that reaches beyond shipping a sensor. The company needs patients who will keep measuring, doctors who can use the information and local relationships that carry the service into another health system.
That combination runs through the founding team. Cardiologist Tomáš Skála leads research, David Skála leads product, and Stephen Burke helped start the company after discussing the difficulty of heart monitoring with Tomáš Skála. Clinical judgment and software development were in the same conversation early.
According to the investor announcement, Kardi Ai now reaches more than 6,000 users and works with over 70 Czech hospitals and more than 20 corporate and benefit partners. Those are reported reach figures. They leave the economics of individual deployments open, while showing how many different relationships sit around a device worn by one person.
Germany is a priority following pilots, with expansion also planned across Asia. The new capital will help fund that work alongside development of models intended to estimate future arrhythmia risk from repeated measurements. Those predictive capabilities still need clinical validation and regulatory approval before medical use.
The service already gives physicians ECG information to support care. Moving further toward prediction would ask them to make sense of a different kind of signal: a warning about risk before an episode appears. Hrabal's team is financing the work needed to earn that additional place in the clinical conversation.
For the next doctor receiving a patient's measurement history, the useful part of this expansion will arrive as information they can bring into the next appointment.
Deeper Analysis 👇 https://devcuration.com/articles/kardi-ai-raises-5-3m-series-a-heart-monitoring
Opdo
Yousef Arzhangnia has published a thermal-camera lens design that holds focus across a 125°C temperature span. He also tells readers the lens has never been built. For a CTO selling AI into optical engineering, keeping those 2 facts together is a useful place to start.
Opdo wants to carry a customer's project through that distance between a promising simulation and a part somebody can measure. Co-founder and CEO Stephan Kuehr and co-founder and CTO Yousef Arzhangnia have raised a $2.3M pre-seed led by Angular Ventures, with Inflection and Tiny Supercomputer Investment Company participating. The company announced the round on November 12.
The agents work inside Zemax and CODE V, where optical engineers already make design decisions. Opdo adds its own engineering capacity and can source prototypes and finished components. That gives a customer somewhere to take the questions that survive the first attractive design: who can manufacture it, which tolerances matter, and what arrived from the supplier?
Arzhangnia's thermal-camera example makes the work tangible. The team rebuilt a published 2-lens design, found that scaling it exposed material limits, and moved to 3 lenses. The reported focus shift stays within 5 micrometres in nominal simulation. Engineers chose the requirements and the design direction; agents handled searches, modelling and checks. Physical fabrication and testing remain ahead of that example.
Kuehr previously co-founded 3YOURMIND, which automates distributed manufacturing. Opdo now connects another design discipline to the practical demands of making things. Its parts service says measurements feed back into subsequent designs, giving the team a way to learn from the difference between the model and the object. For the buyer, that joins 2 purchasing decisions that often sit apart: the expertise to finish a design and the supplier capable of delivering the hardware.
Inflection's investment thesis follows that feedback toward a neutral optical foundry. That is a long-term ambition, and it helps explain why the firm is backing a business spanning software, engineering services and physical components. Each customer project can create work for the engineers and evidence for the next model.
The new capital goes toward engineering capabilities, AI tooling and more customer projects. Opdo is recruiting optical designers, photonics engineers and metrology experts, the people who can follow a design all the way to the instrument that measures the finished part.
Deeper Analysis 👇 https://devcuration.com/articles/opdo-raises-2-3m-pre-seed-optical-engineering
Securitize / River One
River One lets borrowers keep their working lives in dollars while stablecoin capital supplies the financing behind them. That choice gives a finance team a different reason to take the meeting: another source of credit that can fit the business it already runs.
Securitize wants to own that conversation earlier. On November 9, the tokenization company signed a definitive agreement to acquire River Credit Labs Inc., known as River One, and add warehouse financing to its issuance and servicing infrastructure. Closing is expected in Q4 2026, subject to customary conditions; the price was not disclosed.
A warehouse facility gives a lender capital against a pool of loans or receivables, helping it fund originations while repayments arrive over time. Somebody still has to evaluate that pool, establish which assets qualify, watch performance and decide how much can be advanced. The borrower needs an answer it can build a lending operation around.
Braham Mehta, Co-founder and CEO of River One, has put structuring, underwriting, collateral monitoring and funding operations inside the same proposition. The New York company was founded in 2025, incubated by Framework Ventures and backed by Framework Ventures and Maple Finance. Its thesis describes borrowers drawing and repaying in USD, with stablecoin conversion handled inside the financing structure.
For Carlos Domingo, Securitize's Chairman and CEO, the attraction is a larger role around the asset. Financing can bring Securitize into a relationship before there is a finished product to tokenize, then keep it involved as that portfolio develops. The announcement describes additional institutional financing revenue as an opportunity, with the business still to be built.
That changes the sales discussion. A treasury team can consider a different capital provider without signing up to operate a crypto treasury. A credit team still needs satisfactory collateral rules, legal protections and a clear response when collections deteriorate. River One's proposition has to make sense to both teams in the same institution.
The useful detail is how much familiar work remains inside the new financing model. Someone must keep the asset data current, reconcile the borrowing position and know which action follows a change in the pool. Those are the conversations Securitize would inherit alongside the technology, each time an originator comes back for its next draw.
Yamaha / Disguise
Ashraf Nehru built a 3D visualizer that became the foundation for Disguise's Designer software. Around that tool grew a community of people who could imagine a show, prepare it and make it happen in front of an audience.
Yamaha Corporation now wants to bring that business inside its own. The November 13 agreement covers all shares of Butterfly Topco, Disguise's parent, with £215M in consideration for ordinary shares and shareholder loan notes. Completion is scheduled for December, subject to regulatory approvals, and the final consideration will be set at closing.
If the deal closes, Disguise CEO Fernando Küfer would lead a company shaped by live productions as it joins an owner with a very different reach. Yamaha President and Representative Executive Officer Atsushi Yamaura wants sound and music to lead into experiences across whole venues. Disguise supplies much of the visual-production knowledge that makes that ambition practical.
There is a useful commercial connection here. A venue buying audio also needs pictures, lighting and media to behave together. Yamaha would gain software, hardware and services that participate in the production from its earliest design work through playback, with a route to offer more of the brief through the same group.
Livingbridge first invested in 2017 and reinvested alongside the 2021 deal. That history includes The Carlyle Group's majority investment in 2021, alongside a minority investment from Epic Games. Carlyle subsequently backed expansion through acquisitions including Meptik, Mapping Matter, Previz and Polygon Labs. Carlyle's sale would hand a broader business to an industrial buyer looking to connect those capabilities with its own distribution.
Raed Al Tikriti, Disguise's Chief Product & Tech Officer, works in a business where the virtual plan eventually meets a physical room. OmniCal, for example, calibrates projection against real surfaces and supports recalibration when equipment moves. The work keeps returning to the people who have to deliver the production.
Disguise says customers will keep working with the same teams, with more on the combined roadmap in 2027. That continuity has commercial weight: crews carry experience with the software, partners carry customer relationships, and a show already in preparation still needs support while the ownership paperwork catches up.
Yamaha's wider reach could put Disguise in more rooms. Küfer's teams will still be the people helping a production get from its Designer project to the audience waiting outside.
Deeper Analysis 👇 https://devcuration.com/articles/yamaha-agrees-acquire-disguise-live-production
Rowan Digital Infrastructure
Rowan's November 12 package adds $1.545B of corporate credit capacity across three instruments, each with a different job. Apterra Infrastructure Capital led a $600M term-loan increase. Citibank led both a $590M revolver and a $355M letter-of-credit facility. The letters of credit can cover utility interconnection deposits and obligations to equipment vendors without Rowan posting cash.
The Apterra facility grows from $300M to $900M. The revolver lets Rowan draw, repay and redraw as projects advance. Each instrument answers a different question about when money is needed and what somebody else needs guaranteed.
CEO Charley Daitch previously led energy and water strategy teams at AWS. His current business develops build-to-suit hyperscale campuses, where a promising location has to survive conversations about grid access, water, equipment and the people living nearby. The company's founding sponsor, Quinbrook, began Rowan in 2020 around the value of strategically located powered land. Blackstone now backs the business alongside Quinbrook.
Rowan reports a 5.5 GW development pipeline and more than 1.2 GW contracted to technology customers. Contracted capacity carries a delivery assignment; the release does not identify those customers or say that all of that capacity is operating.
Corporate facilities give the development team a source of capital across sites. Earlier project financings paid for particular campuses, including nearly $3B for the 300 MW Temple development. The new structure reaches further back into the decisions that make a campus financeable in the first place. Rowan says it has arranged more than $8B in financings from over 40 lenders in 18 months, giving this corporate package a substantial project-finance history.
For a hyperscale buyer, Rowan's offer includes taking responsibility for that sequence. For the finance team, preserving cash while meeting a utility's security requirement makes the next land or equipment decision easier to approach. As more sites move forward, those commitments keep arriving on different calendars.
Closing Signal
What Someone Can Act On
A utility, a cardiologist and the crew preparing a live show may never read the headline attached to the companies they depend on. They have more immediate things on their minds: whether a commitment is backed, whether a patient's recording is available and whether the setup they rehearsed will still work.
Watch the next decision each company asks somebody else to make. Rowan has arranged credit; look for the obligations that capacity actually helps it meet. Kardi Ai can collect readings outside the exam room; watch what arrives in a form a clinician can use. If Yamaha completes its Disguise purchase, notice what it preserves for the production crews who already rely on the tools.
The week offers plenty of reasons to pay attention to the size of a check. The detail worth carrying into next week is what a person can do with the promise behind it, and what they still have to wait for.
FREE PUBLICATION · EVERY EDITION
Every issue. Delivered when it publishes.
WTMM is currently free. Subscribe once and receive every Daily, Sunday, Monthly, and future edition automatically.NO CARD REQUIRED